Martin Birkhofer
- Immunology top 10%
- Oncology
- Hematology top 10%
- Rheumatology top 10%
- Radiology, Nuclear Medicine and Imaging
- Co-authors
- Kapil N. BhallaGerald G. KruegerNicholas J. LoweKaren BerryMichael GoldfarbRussell WeinerJames G. KruegerMark Lebwohl
- Topics
- Cancer Treatment and Pharmacology (5 papers)Chemotherapy-induced organ toxicity mitigation (4 papers)Colorectal Cancer Treatments and Studies (3 papers)
- Cited by
- ImmunologyHematologyTransplantation
- Partner nations
- United StatesGermanyNetherlands
In The Last Decade
Martin Birkhofer
20 papers receiving 772 citations
Peers
Comparison fields: 5 of 84
- Immunology 371
- Oncology 186
- Hematology 140
- Rheumatology 122
- Radiology, Nuclear Medicine and Imaging 97
Countries citing papers authored by Martin Birkhofer
This map shows the geographic impact of Martin Birkhofer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martin Birkhofer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martin Birkhofer more than expected).
Fields of papers citing papers by Martin Birkhofer
This network shows the impact of papers produced by Martin Birkhofer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martin Birkhofer. The network helps show where Martin Birkhofer may publish in the future.
Co-authorship network of co-authors of Martin Birkhofer
This figure shows the co-authorship network connecting the top 25 collaborators of Martin Birkhofer. A scholar is included among the top collaborators of Martin Birkhofer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martin Birkhofer. Martin Birkhofer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 4 | |
| 3 | 4 | |
| 4 | 51 | |
| 5 | 15 | |
| 6 | 473 | |
| 7 | 65 | |
| 8 | Oral UFT plus leucovorin in patients with relapsed or refractory colorectal cancer. | 5 |
| 9 | 8 | |
| 10 | 1 | |
| 11 | 26 | |
| 12 | 5 | |
| 13 | 8 | |
| 14 | 3 | |
| 15 | Differential effect of interleukin 3 on the metabolism of high-dose cytosine arabinoside in normal versus leukemic human bone marrow cells. | 9 |
| 16 | 1 | |
| 17 | 17 | |
| 18 | The effect of recombinant human granulocyte-macrophage colony-stimulating factor (rGM-CSF) on 3'-azido-3'-deoxythymidine (AZT)-mediated biochemical and cytotoxic effects on normal human myeloid progenitor cells. | 47 |
| 19 | Continuously Administered 2',2'-Difluorodeoxycytidine (Dfdc) and Deoxycytidine (Dcyd) - a Potentially Selective Cyto-Toxic Regimen Toward Human-Leukemic Myeloid Progenitors in Culture | 2 |
| 20 | Effect of recombinant GM-CSF on the metabolism of cytosine arabinoside in normal and leukemic human bone marrow cells. | 57 |
About Martin Birkhofer
Martin Birkhofer is a scholar working on Virology, Reproductive Medicine and Oncology, having authored 20 papers that have together received 802 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (5 papers), Chemotherapy-induced organ toxicity mitigation (4 papers) and Colorectal Cancer Treatments and Studies (3 papers). The work is most often cited by research in Immunology (371 citations), Hematology (140 citations) and Transplantation (30 citations). Martin Birkhofer has collaborated with scholars based in United States, Germany and Netherlands. Frequent co-authors include Kapil N. Bhalla, Gerald G. Krueger, Nicholas J. Lowe, Karen Berry, Michael Goldfarb, Russell Weiner, James G. Krueger, Mark Lebwohl, Alan Menter and Garvin L. Warner. Their work appears in journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.